1. Introduction
Cat cafés are a popular type of coffee or tea shop which allows customers to play with cats that roam freely around the café. The prominent level of cat–cat and human–cat interactions, including the influx of daily customers, may facilitate the transmission of veterinary and zoonotic pathogens. A recent study found that the average number of times cats in a cat café were sick was greater than that for cats in foster care in the same geographic area [
1]. There is evidence of human cases of giardiasis from the zoonotic agent
Giardia duodenalis originating in cat cafés [
2]. Similarly, in China, cat cafés are suspected of contributing to the rise in
Pasteurella multocida cases in humans [
3].
Since its initial discovery in China in 2019, SARS-CoV-2 has been the cause of one of the largest pandemics in human history. SARS-CoV-2 has been confirmed to infect a wide variety of mammalian hosts, which is attributed to its entry via the ACE-2 receptor [
4]. Domestic cats may become infected with SARS-CoV-2 through contact with other infected cats, infected humans, or SARS-CoV-2-contaminated environments [
5]. While many infected cats are asymptomatic [
6], some may display clinical signs similar to those of human COVID-19 infections, including respiratory distress, coughing, sneezing, fever, nasal discharge, and others [
7].
In rare circumstances, SARS-CoV-2-infected animals have been the source of infection to humans, including an instance of cat to human transmission [
8]. Among the central Texas pets living in houses with confirmed human cases of SARS-CoV-2 early on in the pandemic, 36–43.8% of felines were found to have been infected with the virus [
9]. Outside of the home, shelters and farms have also investigated SARS-CoV-2 transmission among felines. In shelters, where cats are often in close and sustained proximity with each other as well as human caregivers, seropositivity ranges from 0.8 to 10% [
10,
11,
12,
13]. Cats residing on mink farms have displayed seropositivity as high as 18% [
14]. To date, no studies have investigated SARS-CoV-2 transmission dynamics among felines residents in a cat café. In rare circumstances, SARS-CoV-2-infected animals have been the source of infection to humans, including an instance of cat-to-human transmission [
8].
2. Materials and Methods
We quantified the level of SARS-CoV-2 exposure and infection among the feline residents of a new cat café in Brazos County, Texas, which opened in September 2021. The establishment consisted of an approximate 200 ft2 public room with tables, chairs, cat beds, cat trees, and numerous toys and enrichment activities for the cats. To enter the café, customers paid a small fee of USD 7 per hour. The café was open 8 h daily, 7 days per week, and a range of 40–100 unique customers visited the café daily during the period of our study (café management, personal communication). At the café’s opening, all resident cats were purebred and arrived at the café after being purchased from breeders or other homes. While many of the resident cats from the initial sampling point remained at the café through the last sampling point, several others were added through partnerships with local humane societies and adoption from other homes.
Given the total population size of ~30 cats at the cat café, our representation of 25 of these cats across our study affords us 95% confidence that our calculated period prevalence is within 5% of true prevalence, given an anticipated 8% SARS-CoV-2 seroprevalence, based on the literature [
15]. Cats were sampled opportunistically at 4 time periods in 2021–2022, approved by TAMU’s Institutional Animal Care and Use Committee. All cats who were approved by the café owner were sampled, with no restrictions in the selection criteria. Information on the sex and breed of cats was included, but information on age was not available. Nasal, oral, rectal, and external body (fur) swabs, immersed into 3 mL viral transport media (VTM; made following CDC SOP#: DSR-052-02), and blood samples were collected.
Swabs were tested for SARS-CoV-2 RNA using qRT-PCR by targeting a conserved region of the RdRp gene. Primers and a probe were designed based on a stable region of the viral genome to ensure broad detection across SARS-CoV-2 variants. The primer sequences used were RdRp_SARSr-F2 (GTGARATGGTCATGTGTGGCGG; 600 nM final concentration, IDT Cat. #10006882) and RdRp_SARSr-R1 (CARATGTTAAASACACTATTAGCATA; 800 nM, IDT Cat. #10006883), with probe sequence RdRp_SARSr-P2 (FAM-CAGGTGGAACCTCATCAGGAGATGC-BBQ; 100 nM, IDT Cat. #10006886). Reactions were carried out using the TaqMan Fast Virus 1-Step Kit (Thermo Fisher Scientific, Waltham, MA, USA) according to the manufacturer’s protocol. Thermal cycling conditions were as follows: reverse transcription at 50 °C for 30 min, initial denaturation at 95 °C for 15 min, followed by 45 amplification cycles of 95 °C for 15 s and 58 °C for 60 s. A synthetic 2019-nCoV_RdRp (ORF1ab) RNA control was included as a positive control in each run.
Sera were assayed for SARS-CoV-2-neutralizing antibodies using plaque reduction neutralization tests against SARS-CoV-2 Isolate USAIL1/2020, NR 52381 (BEI Resources, Manassas, VA, USA) following methods we previously reported [
16]. Samples which neutralized viral plaques by 50% or more (PRNT
50) were interpreted as seropositive. Those that were able to neutralize viral plaques by 90% or more (PRNT
90) were further tested in 2-fold dilutions, starting at 1:10, to determine 90% endpoint titers. Although the PRNT approach does not afford differentiation between IgG and IgM responses, the presence of neutralizing activity, particularly in the later stages post-infection, is likely attributable to IgG, which is typically responsible for longer-term antiviral immunity.
3. Results
In total, 25 unique cats were sampled across four café visits between 30 September 2021, and 14 October 2022, yielding 120 swabs and 40 blood samples in total. All qRT-PCR tests on swabs were negative. Of these 25 cats, 22 were blood-sampled at least once, and 11 of them harbored SARS-CoV-2-neutralizing antibodies using a PRNT
50 cutoff for a 13-month period prevalence of 50%. Four cats also met the PRNT
90 positivity criteria, all of which had endpoint titers of 10 (
Table 1).
Of these 11 seropositive cats, 3 were male, 8 were female, and 9 were purebred (
Table 1). A chi-squared test revealed no significant effect of sex on seropositivity (
p = 0.0734,
Table 2). Additionally, we performed Fisher’s exact test to investigate the effect of breed on seropositivity, and found that purebred cats were significantly more likely to be positive than domestic short- and long-hair cats (
p = 0.04638,
Table 2).
The proportion of cats who were seropositive varied over time, with a peak of 100% (seven out of seven) in November 2021 when Delta was predominant in humans, with a lower proportion of them being seropositive in 2022 once Omicron emerged (
Figure 1). Three cats negative on the initial sampling date, 30 September 2021—the same month the café opened to the public—were later positive in November 2021, suggesting new infections were acquired between 30 September and early November 2021, when cats likely became accustomed to frequent interactions with customers. On 28 January 2022, 5 of 12 (41.6%) cats were seropositive. The collection took place after the introduction of Omicron to Brazos County, but Delta was still the primary variant circulating at this time (
Figure 1). Four of these twelve cats had been previously sampled in November, including three previously seropositive cats that seroreverted to negative, and one cat that remained positive 2.5 months later. Finally, on 14 October 2022 when the Omicron variant was dominant in the human population, only 1 of the 17 cats tested was seropositive (5.9%), and 7 cats were new to the café and had not been previously sampled. The single seropositive cat was also positive in January 2022, suggesting the retention of neutralizing antibodies for at least 8 months or the acquisition of a new infection, whereas four previously seropositive cats had reverted to seronegative. Consistent with our findings, a prior study showed long-term immunity in domestic cats 3–8 months past the initial positive testing date [
17], and immunity to SARS-CoV-2 in cats has been shown to protect against re-infection [
13]. Further, the lower proportion of seropositive cats at the end of our study supports the findings of experiments showing that Omicron is less infectious to felines [
18]. Notably, our study also did not report the specific variants observed in the cat population of the café, and confirmation of the circulating variant is needed to make strong conclusions about the effect of SARS-CoV-2 variants on feline seropositivity.
4. Discussion
Studies of pet cats in households with confirmed COVID-19 cases in Texas, Washington, Utah, Idaho, and Ontario, Canada, showed that 31–52% of cats were seropositive for SARS-CoV-2, with risk factors for cat infection including sleeping in a bed with owners, or being held, petted, and kissed by infected owners [
19,
20,
21]. In contrast, despite the considerable number of human interactions each café cat in our study may have had, the interactions were brief, with most patrons spending only an hour or two at the café, and customers were not allowed to pick up or kiss the cats. This is consistent with research on best practices for human–cat interactions with café cats, which suggest that short, limited touch is ideal for feline comfort in this environment and may have mitigated further SARS-CoV-2 transmission. Additional protective behaviors, including visitor screening and the isolation of sick cats, could also be employed at cat cafés and similar environments.
We found that the highest seropositivity throughout the study was in January of 2021, when the Delta variant was prominent in the human population throughout Brazos County. Conversely, we found the lowest seropositivity after the Omicron variant became predominant. Similarly, other studies have found higher rates of feline infection with the Delta variant compared to the Omicron variant, both in laboratory and field settings, and our findings may support this idea [
18,
22,
23].
Purebred cats may have increased susceptibility to several genetic and infectious diseases due to the nature of their breeding [
24,
25]. Many of the resident cats in the café were purebred (68%). We found that purebred cats were significantly more likely to have SARS-CoV-2-neutralizing antibodies compared to non-purebred cats. This is consistent with previous studies which found domestic purebred and pedigree cats more susceptible to the SARS-CoV-2 than non-purebred cats, potentially owing to the genetics associated with selective breeding [
26].
Sampling bias may have been introduced into the study design because not all cats were made available by the café owner at all sampling time points, with a couple of cats being restricted from the research team due to owner-disclosed behavioral problems or sickness. However, their omission from the study does not change the infection outcomes in the cats we measured. Further, given our small sample size, limited sampling periods, and the fact that we only sampled one café, our study may not be representative of the risk of feline SARS-CoV-2 infection across all cat cafés or aggregate cat settings. This café in Brazos County ultimately closed in February of 2023, citing financial issues as a reason. Notably, the café posted that they were dealing with several cases of zoonotic pathogens in the café during the period of sampling on their social media, including cases of Tritrichomonas foetus, ringworm (Microsporum canis), and Bartonella. Zoonotic disease mitigation should be considered in all cat cafés.
5. Conclusions
Cat cafés may be high-risk settings for the transmission of SARS-CoV-2, with varying patterns of cat infection across different waves of the pandemic. Such residential cats with no or limited travel outside of the café may serve as effective sentinels for the dynamics of transmission in the local human community.
Author Contributions
Sample collection, C.D., L.D.A. and S.A.H. Preparation of initial manuscript text, C.D. Virology studies, W.T. and G.L.H. Funding, C.D., G.L.H. and S.A.H. Conceptualization, C.D. and S.A.H. Methodology, W.T., G.L.H. and S.A.H. Formal analysis, C.D. Investigation, L.D.A., C.D., S.A.H. and W.T. Resources, G.L.H. and S.A.H. Writing—original draft preparation, C.D. Writing—review and editing, C.D., L.D.A., W.T., G.L.H. and S.A.H. Supervision, S.A.H. Funding acquisition, G.L.H., C.D. and S.A.H. All authors have read and agreed to the published version of the manuscript.
Funding
This study was supported by the Sigma Xi Grants of Aid in Research [G20221001-4207] and Texas A&M AgriLife Research.
Institutional Review Board Statement
The animal study protocol was approved by the Texas A&M University Institutional Committee on Animal Use and Care (IACUC) with owner consent overseen by the Clinical Research and Review Committee (protocol code IACUC 2018-0460 CA; date of approval 6 February 2019).
Informed Consent Statement
Informed consent was obtained from all the owner of animals involved in the study.
Data Availability Statement
The original contributions presented in this study are included in the article. Further inquiries can be directed to the corresponding author(s).
Acknowledgments
We thank the management of the cat café for allowing our team to sample the animals. We thank Italo Zecca, Rachel Busselman, Ed Davila, and Chris Roundy for the assistance with sampling and serologic analysis.
Conflicts of Interest
The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Abbreviations
The following abbreviations are used in this manuscript:
ACE-2 | Angiotensin-converting enzyme 2 |
COVID-19 | Coronavirus disease 2019 |
PRNT | Plaque reduction neutralization test |
SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 |
qRT-PCR | Quantitative reverse transcriptase polymerase chain reaction |
VTM | Viral transport media |
References
- Ropski, M.K.; Pike, A.L.; Ramezani, N. Analysis of illness and length of stay for cats in a foster-based rescue organization compared with cats housed in a cat café. J. Vet. Behav. 2023, 62, 1–11. [Google Scholar] [CrossRef]
- Suzuki, J.; Murata, R.; Kobayashi, S.; Sadamasu, K.; Kai, A.; Takeuchi, T. Risk of human infection with Giardia duodenalis from cats in Japan and genotyping of the isolates to assess the route of infection in cats. Parasitology 2011, 138, 493–500. [Google Scholar] [CrossRef] [PubMed]
- Lin, H.; Liu, Z.; Zhou, Y.; Lu, W.; Xu, Q. Characterization of Resistance and Virulence of Pasteurella multocida Isolated from Pet Cats in South China. Antibiotics 2022, 11, 1387. [Google Scholar] [CrossRef] [PubMed]
- Wang, Q.; Zhang, Y.; Wu, L.; Niu, S.; Song, C.; Zhang, Z.; Lu, G.; Qiao, C.; Hu, Y.; Yuen, K.Y.; et al. Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2. Cell 2020, 181, 894–904.e9. [Google Scholar] [CrossRef]
- Gerhards, N.M.; Gonzales, J.L.; Vreman, S.; Ravesloot, L.; van den Brand, J.M.; Doekes, H.P.; Egberink, H.F.; Stegeman, A.; Oreshkova, N.; Van der Poel, W.H.; et al. Efficient Direct and Limited Environmental Transmission of SARS-CoV-2 Lineage B.1.22 in Domestic Cats. Microbiol. Spectr. 2023, 11, e02553-22. [Google Scholar]
- Gaudreault, N.N.; Trujillo, J.D.; Carossino, M.; Meekins, D.A.; Morozov, I.; Madden, D.W.; Indran, S.V.; Bold, D.; Balaraman, V.; Kwon, T.; et al. SARS-CoV-2 infection, disease and transmission in domestic cats. Emerg. Microbes Infect. 2020, 9, 2322–2332. [Google Scholar] [CrossRef] [PubMed]
- Liew, A.Y.; Carpenter, A.; Moore, T.A.; Wallace, R.M.; Hamer, S.A.; Hamer, G.L.; Fischer, R.S.; Zecca, I.B.; Davila, E.; Auckland, L.D.; et al. Clinical and epidemiologic features of SARS-CoV-2 in dogs and cats compiled through national surveillance in the United States. J. Am. Vet. Med. Assoc. 2023, 261, 480–489. [Google Scholar] [CrossRef]
- Sila, T.; Sunghan, J.; Laochareonsuk, W.; Surasombatpattana, S.; Kongkamol, C.; Ingviya, T.; Siripaitoon, P.; Kositpantawong, N.; Kanchanasuwan, S.; Hortiwakul, T.; et al. Suspected Cat-to-Human Transmission of SARS-CoV-2, Thailand, July–September 2021. Emerg. Infect. Dis. 2022, 28, 1485–1488. [Google Scholar] [CrossRef]
- Pauvolid-Corrêa, A.; Davila, E.; Auckland, L.D.; Zecca, I.B.; Busselman, R.E.; Tang, W.; Roundy, C.M.; Killian, M.L.; Torchett, M.K.; Jenkins-Moore, M.; et al. Active surveillance of cats and dogs from households with human COVID-19 cases reveals 2 over one quarter of pets infected with SARS-CoV-2 in 2020–2021 in Texas, United States. bioRxiv 2025. [Google Scholar] [CrossRef]
- Van der Leij, W.J.R.; Broens, E.M.; Hesselink, J.W.; Schuurman, N.; Vernooij, J.C.; Egberink, H.F. Serological Screening for Antibodies against SARS-CoV-2 in Dutch Shelter Cats. Viruses 2021, 13, 1634. [Google Scholar] [CrossRef]
- Mazzotta, E.; Lucchese, L.; Corrò, M.; Ceglie, L.; Danesi, P.; Capello, K.; Natale, A. Zoonoses in dog and cat shelters in North-East Italy: Update on emerging, neglected and known zoonotic agents. Front. Vet. Sci. 2024, 11, 1490649. [Google Scholar] [CrossRef] [PubMed]
- Go, Y.Y.; Carrai, M.; Choi, Y.R.; Brackman, C.J.; Tam, K.W.; Law, P.Y.; Woodhouse, F.; Gray, J.; Kim, J.H.; Park, J.; et al. Low Prevalence of SARS-CoV-2 Antibodies in Canine and Feline Serum Samples Collected during the COVID-19 Pandemic in Hong Kong and Korea. Viruses 2023, 15, 582. [Google Scholar] [CrossRef]
- Bienzle, D.; Rousseau, J.; Marom, D.; MacNicol, J.; Jacobson, L.; Sparling, S.; Prystajecky, N.; Fraser, E.; Weese, J.S. Risk Factors for SARS-CoV-2 Infection and Illness in Cats and Dogs. Emerg. Infect. Dis. 2022, 28, 1154–1162. [Google Scholar] [CrossRef]
- Van Aart, A.E.; Velkers, F.C.; Fischer, E.A.; Broens, E.M.; Egberink, H.; Zhao, S.; Engelsma, M.; Hakze-van der Honing, R.W.; Harders, F.; de Rooij, M.M.; et al. SARS-CoV-2 infection in cats and dogs in infected mink farms. Transbound. Emerg. Dis. 2022, 69, 3001–3007. [Google Scholar] [CrossRef]
- Dileepan, M.; Di, D.; Huang, Q.; Ahmed, S.; Heinrich, D.; Ly, H.; Liang, Y. Seroprevalence of SARS-CoV-2 (COVID-19) exposure in pet cats and dogs in Minnesota, USA. Virulence 2021, 12, 1597–1609. [Google Scholar] [CrossRef]
- Roundy, C.M.; Nunez, C.M.; Thomas, L.F.; Auckland, L.D.; Tang, W.; Richison, J.J., III; Green, B.R.; Hilton, C.D.; Cherry, M.J.; Pauvolid-Corrêa, A.; et al. High Seroprevalence of SARS-CoV-2 in White-Tailed Deer (Odocoileus virginianus) at One of Three Captive Cervid Facilities in Texas. Microbiol. Spectr. 2022, 10, e00576-22. [Google Scholar] [CrossRef] [PubMed]
- Decaro, N.; Grassi, A.; Lorusso, E.; Patterson, E.I.; Lorusso, A.; Desario, C.; Anderson, E.R.; Vasinioti, V.; Wastika, C.E.; Hughes, G.L.; et al. Long-term persistence of neutralizing SARS-CoV-2 antibodies in pets. Transbound. Emerg. Dis. 2022, 69, 3073–3076. [Google Scholar] [CrossRef]
- Martins, M.; do Nascimento, G.M.; Nooruzzaman, M.; Yuan, F.; Chen, C.; Caserta, L.C.; Miller, A.D.; Whittaker, G.R.; Fang, Y.; Diel, D.G. The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS CoV-2 Infection. J. Virol. 2022, 96, e00961-22. [Google Scholar] [CrossRef] [PubMed]
- Hamer, S.A.; Pauvolid-Corrêa, A.; Zecca, I.B.; Davila, E.; Auckland, L.D.; Roundy, C.M.; Tang, W.; Torchetti, M.K.; Killian, M.L.; Jenkins-Moore, M.; et al. SARS-CoV-2 Infections and Viral Isolations among Serially Tested Cats and Dogs in Households with Infected Owners in Texas, USA. Viruses 2021, 13, 938. [Google Scholar] [CrossRef]
- Meisner, J.; Baszler, T.V.; Kuehl, K.E.; Ramirez, V.; Baines, A.; Frisbie, L.A.; Lofgren, E.T.; de Avila, D.M.; Wolking, R.M.; Bradway, D.S.; et al. Household Transmission of SARS-CoV-2 from Humans to Pets, Washington and Idaho, USA. Emerg. Infect. Dis. 2022, 28, 2425–2434. [Google Scholar] [CrossRef]
- Goryoka, G.W.; Cossaboom, C.M.; Gharpure, R.; Dawson, P.; Tansey, C.; Rossow, J.; Mrotz, V.; Rooney, J.; Torchetti, M.; Loiacono, C.M.; et al. One Health Investigation of SARS-CoV-2 Infection and Seropositivity among Pets in Households with Confirmed Human COVID-19 Cases-Utah and Wisconsin, 2020. Viruses 2021, 13, 1813. [Google Scholar] [CrossRef] [PubMed]
- Jones, S.; Tyson, G.B.; Orton, R.J.; Smollett, K.; Manna, F.; Kwok, K.; Suárez, N.M.; Logan, N.; McDonald, M.; Bowie, A.; et al. SARS-CoV-2 in Domestic UK Cats from Alpha to Omicron: Swab Surveillance and Case Reports. Viruses 2023, 15, 1769. [Google Scholar] [CrossRef] [PubMed]
- Klein, C.; Michelitsch, A.; Allendorf, V.; Conraths, F.J.; Beer, M.; Denzin, N.; Wernike, K. Dogs and Cats Are Less Susceptible to the Omicron Variant of Concern of SARS-CoV-2: A Field Study in Germany, 2021/2022. Transbound. Emerg. Dis. 2023, 2023, 1868732. [Google Scholar] [CrossRef]
- El-Tholoth, M.; Hussein, M.; Mohammed, D.; Al-Rasheedi, M.; Al-Qubaisi, H.; Al-Blooshi, A.; Al-Ahbabi, M.; Al-Dhaheri, Z.; Al-Blooshi, K.; Al-Herbawi, M.; et al. Serological Investigation on the Presence of Feline Coronavirus (FCoV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Domestic Cats Living with COVID-19 Positive Owners in the UAE, 2022. Animals 2023, 13, 493. [Google Scholar] [CrossRef]
- Malik, R. Genetic diseases of cats. J. Feline. Med. Surg. 2001, 3, 109–113. [Google Scholar] [CrossRef]
- Tyson, G.B.; Jones, S.; Montreuil-Spencer, C.; Logan, N.; Scott, S.; Sasvari, H.; McDonald, M.; Marshall, L.; Murcia, P.R.; Willett, B.J.; et al. Increase in SARS-CoV-2 Seroprevalence in UK Domestic Felids Despite Weak Immunogenicity of Post-Omicron Variants. Viruses 2023, 15, 1661. [Google Scholar] [CrossRef]
| Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).